How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...

2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the ...

Scaling personalized therapies brings unique logistical challenges. Unlike mass-market drugs, these treatments require highly ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...

Drugmakers, academics and logistics professionals are using artificial intelligence to address the industry’s most pressing ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

Health systems will work to expand their supply chains and ink nontraditional partnerships in 2025, while trimming excessive ...

Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability ...

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for ...